India Point of Care Diagnostics Market Trends, Growth, Share and Forecast 2025-2033

India Point of Care Diagnostics Market Overview

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Size in 2024: USD 1.35 Million

Market Forecast in 2033: USD 2.98 Million

Market Growth Rate: 8.74% (2025-2033)

The India point of care diagnostics market size was valued at USD 1.35 Million in 2024 and is expected to reach USD 2.98 Million by 2033, exhibiting a CAGR of 8.74% during 2025-2033. 

India Point of Care Diagnostics Market Trends:

India's point-of-care (POC) diagnostics market is undergoing rapid transformation, driven by technological innovation and evolving healthcare demands. A key trend is the rising adoption of portable and handheld devices, enabling faster test results in decentralized settings such as clinics, pharmacies, and even homes. Moreover, the integration of AI and IoT is revolutionizing POC diagnostics, with smart devices offering real-time data analysis and remote monitoring capabilities. In addition, the growing prevalence of chronic diseases like diabetes and cardiovascular disorders is fueling demand for rapid testing solutions that deliver immediate clinical insights. Furthermore, the shift toward preventive healthcare is accelerating market growth, as consumers increasingly prioritize early detection and wellness monitoring.

Basically, the expansion of telemedicine platforms is creating synergies with POC diagnostics, allowing healthcare providers to offer comprehensive virtual consultations supported by instant test results. Notably, the development of multiplex testing devices capable of detecting multiple analytes from a single sample is gaining traction, improving diagnostic efficiency. The market is also witnessing increased focus on user-friendly designs, catering to non-specialized users in rural and semi-urban areas. Additionally, strategic collaborations between diagnostic companies and tech startups are fostering innovation in affordable, scalable POC solutions tailored to India's diverse healthcare landscape.

Request for a sample copy of this report: https://www.imarcgroup.com/india-point-of-care-diagnostics-market/requestsample

India Point of Care Diagnostics Market Scope and Growth Analysis:

India's POC diagnostics market presents substantial growth opportunities, supported by the country's expanding healthcare infrastructure and rising health awareness. Moreover, the untapped potential in tier-2 and tier-3 cities offers significant scope for market penetration, as improving healthcare access drives demand for decentralized testing solutions. In addition, government initiatives promoting universal health coverage are expected to boost adoption, with policies emphasizing affordable and accessible diagnostic tools. Furthermore, the increasing burden of infectious diseases necessitates rapid diagnostic solutions, positioning POC devices as critical tools for timely disease management.

Basically, while glucose monitoring dominates current demand, segments like infectious disease testing and pregnancy diagnostics are projected to witness accelerated growth due to their clinical urgency and widespread applicability. The market is also benefiting from advancements in microfluidics and biosensor technologies, enabling more accurate and cost-effective POC devices. With rising investments in healthcare digitization and the expansion of diagnostic networks, India's POC diagnostics sector is poised for robust expansion, aligning with global trends toward patient-centric, decentralized healthcare delivery models.

India Point of Care Diagnostics Industry Segmentation:

The report has segmented the market into the following categories:

Analysis by Product Type:

  • Blood-Glucose Monitoring Kit
  • Cardio-Metabolic Monitoring Kit
  • Pregnancy and Fertility Testing Kit
  • Infectious Disease Testing Kit
  • Cholesterol Test Strip
  • Hematology Testing Kit
  • Others

Analysis by Platform:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Analysis by Prescription Mode:

  • Prescription-based Testing
  • OTC Testing

Analysis by End User:

  • Professional Diagnostic Centers
  • Home Care
  • Research Laboratories
  • Others

Regional Analysis:

  • North India
  • West and Central India
  • South India
  • East and Northeast India

Competitor Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. 

Other key areas covered in the report:

  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Strategic Recommendations
  • Market Dynamics
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape
  • Top Winning Strategies
  • Recent Industry News
  • Key Technological Trends & Development

Ask an analyst: https://www.imarcgroup.com/request?type=report&id=21343&flag=C

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145